Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Mangat

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Rheumatology|October 2, 2008
Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapyPamela Mangat, Samuel Whittle, Les Cleland, et al.
Clinical Rheumatology|June 19, 2008
A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis opticaPamela Mangat, Janakan Ravindran, Les Cleland, et al.
Arthritis Research & Therapy|June 18, 2010
Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?Pamela Mangat, Natalia Wegner, Patrick J Venables, et al.
Oxford Medical Case Reports|March 27, 2024
Isotretinoin-induced myositisOliver Hague, Vasiliki Thanopoulou, Pamela Mangat, et al.
Arthritis|March 19, 2015
Early metacarpal bone mineral density loss using digital x-ray radiogrammetry and 3-tesla wrist MRI in established rheumatoid arthritis: a longitudinal one-year observational studyAnshul Rastogi, Jakob Algulin, Pamela Mangat, et al.
Rheumatology (Oxford, England)|September 28, 2020
TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20Mohammed Al-Bogami, Jonas Bystrom, Felix Clanchy, et al.
Mediators of Inflammation|June 24, 2015
Harnessing the Therapeutic Potential of Th17 CellsJonas Bystrom, Taher E Taher, M Sherwan Muhyaddin, et al.
Clinical Reviews in Allergy & Immunology|May 11, 2017
Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF<sup>+</sup> T LymphocytesJonas Bystrom, Felix I Clanchy, Taher E Taher, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Rheumatology|October 2, 2008
Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapyPamela Mangat, Samuel Whittle, Les Cleland, et al.
Clinical Rheumatology|June 19, 2008
A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis opticaPamela Mangat, Janakan Ravindran, Les Cleland, et al.
Arthritis Research & Therapy|June 18, 2010
Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?Pamela Mangat, Natalia Wegner, Patrick J Venables, et al.
Oxford Medical Case Reports|March 27, 2024
Isotretinoin-induced myositisOliver Hague, Vasiliki Thanopoulou, Pamela Mangat, et al.
Arthritis|March 19, 2015
Early metacarpal bone mineral density loss using digital x-ray radiogrammetry and 3-tesla wrist MRI in established rheumatoid arthritis: a longitudinal one-year observational studyAnshul Rastogi, Jakob Algulin, Pamela Mangat, et al.
Rheumatology (Oxford, England)|September 28, 2020
TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20Mohammed Al-Bogami, Jonas Bystrom, Felix Clanchy, et al.
Mediators of Inflammation|June 24, 2015
Harnessing the Therapeutic Potential of Th17 CellsJonas Bystrom, Taher E Taher, M Sherwan Muhyaddin, et al.
Clinical Reviews in Allergy & Immunology|May 11, 2017
Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF<sup>+</sup> T LymphocytesJonas Bystrom, Felix I Clanchy, Taher E Taher, et al.
Pageof 1